Abstract
Background Medication review is time-consuming and not exhaustive in most French hospitals. We routinely use an innovative hybrid decision support system using Artificial Intelligence to prioritize medication review by scoring prescriptions by their risk of containing at least one drug related problem (DRP). Aim Our aim was to attest that the prescriptions with low risk of DRPs ruled out by the tool in everyday practice were effectively free of any DRPs with potentially severe clinical impact. Methods We conducted a randomized single-blinded study to compare the rate of pharmaceutical interventions (PI) between low and high-risk prescriptions defined by the tool’s calculated score. Prescriptions were reviewed daily by a clinical pharmacist. Proportion of prescriptions with at least one severe DRP was calculated in both groups. Severe DRPs were characterized through a multidisciplinary approach. Results Four hundred and twenty (107 low score and 313 high score) prescriptions were analyzed. The percentage of prescriptions with severe DRPs was dramatically decreased in low score prescriptions (2.8% vs. 15.3% for high-risk; p = 0.0248). A significant difference was found (94% vs. 20%; p < 0.001) in the percentage of severe DRPs detected by the hybrid approach compared to a CDSS. During the study period, the hybrid tool allowed to rule out 55% of all prescriptions in our hospital.Conclusion This hybrid decision support tool has shown to be accurate to detect DRPs in daily practice. Despite some limitations, it offers the best possible solution to prioritized medication review, considering the shortage of clinical pharmacists in France and considerably improves the safety of patients’ care.
Similar content being viewed by others
References
Michel P, Lathelize M, Domecq S, et al. Les événements indésirables graves dans les établissements de santé : fréquence, évitabilité et acceptabilité [Internet]. DREES; 2011 May. Report No.: 17. Available from: https://drees.solidarites-sante.gouv.fr/IMG/pdf/article201017.pdf Accessed 04.10.2021.
Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and mortality. Ann Pharmacother. 2018;52:829–37.
Elliott RA, Camacho E, Jankovic D, et al. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2020 bmjqs-2019–010206.
McCarter TG, Centafont R, Daly FN, et al. Reducing medication errors: a regional approach for hospitals. Drug Saf. 2003;26:937–50.
Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65:303–16.
Bates DW, Leape LL, Cullen DJ, et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. JAMA. 1998;280:1311–6.
Arrêté du 6 avril 2011 relatif au management de la qualité de la prise en charge médicamenteuse et aux médicaments dans les établissements de santé [Internet]. Available from: https://www.legifrance.gouv.fr/loda/id/JORFTEXT000023865866/ Accessed 04.10.2021.
Cornuault L, Mouchel V, Phan Thi T-T, et al. Identification of variables influencing pharmaceutical interventions to improve medication review efficiency. Int J Clin Pharm. 2018;40:1175–9.
Corny J, Rajkumar A, Martin O, et al. A machine learning-based clinical decision support system to identify prescriptions with a high risk of medication error. J Am Med Inform Assoc JAMIA. 2020;27:1688–94.
Kang M-S, Choi S-H, Koh I-S. The effect of increasing control-to-case ratio on statistical power in a simulated case-control snp association study. Genomics Inform. 2009;7:148–51.
Juste M. 2012 Recommandation de bonne pratique en pharmacie clinique Analyse d’ordonnance et niveaux d’analyse pharmaceutique. Pharm Hosp Clin 47:293–295.
Vo HT, Charpiat B, Chanoine S, et al. CLEO: a multidimensional tool to assess clinical, economic and organisational impacts of pharmacists’ interventions. Eur J Hosp Pharm Sci Pract. 2021;28:193–200.
Thi Ha Vo. Evaluation of the potential impact of pharmacist interventions : development and valida- tion of the CLEO multidimensional tool Pharmaceutical sciences. Université Grenoble Alpes; 2015.
Allenet B, Bedouch P, Rose F-X, et al. Validation of an instrument for the documentation of clinical pharmacists’ interventions. Pharm World Sci PWS. 2006;28:181–8.
Conort O, Bedouch P, Juste M, et al. Validation d’un outil de codification des interventions de pharmacie clinique. J Pharm Clin. 2004;23:141–7.
Schiff GD, Volk LA, Volodarskaya M, et al. Screening for medication errors using an outlier detection system. J Am Med Inform Assoc JAMIA. 2017;24:281–7.
Rozenblum R, Rodriguez-Monguio R, Volk LA, et al. Using a machine learning system to identify and prevent medication prescribing errors: a clinical and cost analysis evaluation. Jt Comm J Qual Patient Saf. 2020;46:3–10.
Sutton RT, Pincock D, Baumgart DC, et al. An overview of clinical decision support systems: benefits, risks, and strategies for success. Npj Digit Med. 2020;3:17.
Ordre National des Pharmaciens. Démographie des pharmaciens Panorama au 1er janvier 2020 [Internet]. Ordre National des Pharmaciens; 2020 Jan. Available from: http://www.ordre.pharmacien.fr/content/download/506716/2312914/version/1/file/LA-DEMOGRAPHIE-2020.pdf Accessed 04.10.2021.
Alice Bergonzoni, Bénédicte Boisguérin, Hélène Chaput, et al. Etablissements de santé édition 2020 - Direction de la recherche, des études, de l’évaluation et des statistiques [Internet]. 2020. Available from: https://drees.solidarites-sante.gouv.fr/IMG/pdf/es2020.pdf Accessed 04.10.2021.
Funding
No funding was received for conducting this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare that they have no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
In memory of Yvonnick Bezie.
Rights and permissions
About this article
Cite this article
Levivien, C., Cavagna, P., Grah, A. et al. Assessment of a hybrid decision support system using machine learning with artificial intelligence to safely rule out prescriptions from medication review in daily practice. Int J Clin Pharm 44, 459–465 (2022). https://doi.org/10.1007/s11096-021-01366-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-021-01366-4